Showing posts with label
Hemophilia A and B Therapeutics Market Revenue
.
Show all posts
Showing posts with label
Hemophilia A and B Therapeutics Market Revenue
.
Show all posts
Friday, April 7, 2017
Hemophilia A and B Therapeutics in Asia-Pacific Markets to 2022-Growth Driven By Increasing Treatment-Receiving Pool: Ken Research
›
Hemophilia is a rare disease affecting more than 400,000 people worldwide. Hemophilia A is four times as common as hemophilia B, and more ...
›
Home
View web version
